Question 1

What are the most cited papers from Cvergenx (United States)?

Accepted Answer

The most cited paper from Cvergenx (United States) is "Using the genomic adjusted radiation dose (GARD) to personalize the radiation dose in nasopharyngeal cancer" (Chi‐Leung Chiang, Kenneth Sik Kwan Chan, Huaping Li et al., 2024), with 14 citations. Next come "Classification of Radiosensitivity Index by Gaussian Mixture Modelling to Inform Radiotherapy Dose and Discover Disease Subclassifications" (1) and "Radiation Therapy Cytotoxicity Score Predicts Optimal Dose and Fractionation for Individual Patients" (1).

Question 2

Which research topics does Cvergenx (United States) publish most on?

Accepted Answer

By volume in 2022-now: Urinary and Genital Oncology Studies, Bladder and Urothelial Cancer Treatments, Ferroptosis and cancer prognosis and Effects of Radiation Exposure.

Question 3

Which fields of science does Cvergenx (United States) work in?

Accepted Answer

In all years, 71% of research at Cvergenx (United States) is in Health Sciences, 25% in Life Sciences. Its largest fields are Medicine (71%), Biochemistry, Genetics and Molecular Biology (14%), Immunology and Microbiology (11%). It does 1.4× the world's share of Health Sciences.

Question 4

Is Cvergenx (United States)'s research output growing?

Accepted Answer

Output in 2022-2025 was 68% lower than in 2018-2021.